Sato Pharmaceutical Co., Ltd. Deal History & Licensing Activity
Sato Pharmaceutical Co., Ltd. is a life sciences. Over the past three years, Sato Pharmaceutical Co., Ltd. has been involved in 2 licensing and acquisition transactions, with a primary focus on Small Molecules (4 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Small Molecules
Focus Area
Dermatology
Sato Pharmaceutical Co., Ltd. Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Sato Pharmaceutical Co., Ltd. in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| Undisclosed | Novan, Inc. | Small Molecules | Unknown | license | Sep 2025 |
| SB204 | Sato Pharmaceutical Co., Ltd | Small Molecules | Unknown | license | Sep 2025 |
Sato Pharmaceutical Co., Ltd. Pipeline Focus
Therapeutic areas and modalities where Sato Pharmaceutical Co., Ltd. is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Sato Pharmaceutical Co., Ltd.'s Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Dermatology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Small Molecules Benchmarks
Upfront, milestone, and royalty benchmarks for small molecules deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Sato Pharmaceutical Co., Ltd. Licensing & Deal Activity
Sato Pharmaceutical Co., Ltd. is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Sato Pharmaceutical Co., Ltd. ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Sato Pharmaceutical Co., Ltd. include Dermatology (4 deals and trials). In terms of modality, Sato Pharmaceutical Co., Ltd. has shown particular interest in small molecules.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Sato Pharmaceutical Co., Ltd. and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Sato Pharmaceutical Co., Ltd.'s historical deal terms, or explore all company profiles to find the best partner match for your pipeline.